Monitoring molecular changes after kidney transplantation
Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
This study is testing if checking blood and tissue samples can help doctors spot problems early and improve outcomes for people who have received a kidney transplant.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Odense, DK) |
| Trial ID | NCT01515605 on ClinicalTrials.gov |
What this trial studies
This study focuses on the molecular monitoring of patients who have undergone kidney transplantation. It evaluates blood, plasma, urine, and tissue samples to assess the effectiveness of noninvasive diagnostic techniques in improving transplant outcomes. The study involves routine clinical and laboratory data collection at various time points post-transplantation, analyzing gene transcripts and conducting proteomic analyses. The goal is to identify biomarkers that could indicate the success of the transplant and potential complications.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have recently undergone kidney transplantation and can provide informed consent.
Not a fit: Patients who are unable to provide informed consent or have not undergone kidney transplantation will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better management and outcomes for kidney transplant recipients.
How similar studies have performed: Other studies have shown promise in using molecular monitoring techniques for transplant patients, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients after kidney transplantation, male, female, informed consent Exclusion Criteria: * Deny of informed consent
Where this trial is running
Odense, DK
- Odense University Hospital — Odense, Dk, Denmark (Recruiting)
Study contacts
- Principal investigator: Martin Tepel, Dr — Odense University Hospital
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.